# Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG

> **NCT00464451** · PHASE2 · WITHDRAWN · sponsor: **Wesley Medical Center**

## Conditions studied

- Procedural Sedation

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Chloral hydrate

## Key facts

- **NCT ID:** NCT00464451
- **Lead sponsor:** Wesley Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-08
- **Primary completion:** 2010-12
- **Final completion:** 2011-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to obtain approval from FDA for use of chloral hydrate
- **Last updated:** 2016-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00464451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00464451, "Dexmedetomidine Versus Chloral Hydrate for Pediatric Sedation During EEG". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00464451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*